Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Neurogene (NGNE) over the last 3 years, with Q3 2025 value amounting to $9.4 million.

  • Neurogene's Accumulated Expenses fell 971.45% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 971.45%. This contributed to the annual value of $9.7 million for FY2024, which is 4437.84% down from last year.
  • As of Q3 2025, Neurogene's Accumulated Expenses stood at $9.4 million, which was down 971.45% from $9.1 million recorded in Q2 2025.
  • Neurogene's Accumulated Expenses' 5-year high stood at $17.5 million during Q4 2023, with a 5-year trough of $6.8 million in Q1 2024.
  • For the 3-year period, Neurogene's Accumulated Expenses averaged around $9.6 million, with its median value being $9.3 million (2025).
  • Per our database at Business Quant, Neurogene's Accumulated Expenses crashed by 4437.84% in 2024 and then surged by 2733.76% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Accumulated Expenses stood at $17.5 million in 2023, then tumbled by 44.38% to $9.7 million in 2024, then dropped by 3.15% to $9.4 million in 2025.
  • Its Accumulated Expenses was $9.4 million in Q3 2025, compared to $9.1 million in Q2 2025 and $6.8 million in Q1 2025.